Target intelligence / Profile preview

T cell receptor delta diversity 1 (TRDD1)

Target
TRDD1
Molecular classification
Other
01

Overview

T cell receptor delta diversity 1 (TRDD1) is a gene segment that encodes one of the two diversity (D) gene segments within the T cell receptor delta (TRD) locus in humans[1][5]. It is not a protein, enzyme, receptor, or drug target itself, but rather a genomic sequence that contributes to the diversity of the T cell receptor delta chain by participating in V(D)J recombination during T cell development[1][3][4]. These D segments are used as part of the rearrangement process that creates a highly variable antigen recognition domain of the γδ T cell receptor, crucial for immune recognition performed by γδ T cells. Unlike functional receptor proteins, TRDD1 is not itself a therapeutic target, biomarker, or druggable entity, but plays a fundamental role in the genetic mechanisms that generate immune diversity[1][3][5]. ### Key points for structuring: - **TRDD1 is not a receptor or protein**, but a DNA segment; therefore, it is not considered a direct therapeutic target. - The **entry is potentially incorrect if interpreted as a molecular drug target or therapeutic protein**, but technically correct as a gene segment contributing to antigen receptor diversity[5].

Other names
TRDD1T cell receptor delta diversity 1
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on T cell receptor delta diversity 1 (TRDD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor delta diversity 1 (TRDD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call